Skip to main content
SpringerLink
Log in

Another trial for the TARGET trial

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T et al (2022) Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med 48:311–321

    Article  CAS  Google Scholar 

  2. Carrie C, Legeron R, Petit L, Ollivier J, Cottenceau V, d’Houdain N et al (2018) Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion. J Crit Care 48:66–71

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Pharmacokinetics Laboratory, College of Pharmacy and Emerging Pathogens Institute, University of Florida, 1600 SW Archer Rd, Medical Science Building, PO Box 100486, Gainesville, FL, 32610, USA

    Mohammad H. Alshaer & Charles A. Peloquin

  2. Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA

    Mohammad H. Alshaer & Charles A. Peloquin

Authors
  1. Mohammad H. Alshaer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles A. Peloquin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have contributed equally to the conception, drafting, and final editing of this manuscript.

Corresponding author

Correspondence to Mohammad H. Alshaer.

Ethics declarations

Conflicts of interest

The authors have no conflicts to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alshaer, M.H., Peloquin, C.A. Another trial for the TARGET trial. Intensive Care Med 48, 774–775 (2022). https://doi.org/10.1007/s00134-022-06654-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-022-06654-9

Search

Navigation